PATH PATH is a global nonprofit dedicated to achieving health equity.

PATH is a global nonprofit dedicated to achieving health equity so all people and communities can thrive. With 40+ years of experience forging multisector partnerships, and with expertise in science, economics, technology, advocacy, and dozens of other specialties, we develop and scale up innovative solutions to the world’s most pressing health challenges.

Everyone deserves the chance to be healthy, no matter where they live. In low-resource settings, PATH makes good health ...
08/08/2025

Everyone deserves the chance to be healthy, no matter where they live. In low-resource settings, PATH makes good health easier to access by improving health services, creating affordable health products, and advancing health policies.

From 2021–2024, we helped 259 million people access the health products and services they needed.

PATH: The way to better health.

PATH was proud to participate in the Unitaid Grantees Forum, held as part of the UK–South Africa MP Exchange Visit in  ....
08/07/2025

PATH was proud to participate in the Unitaid Grantees Forum, held as part of the UK–South Africa MP Exchange Visit in . The event brought together Unitaid representatives, Members of Parliament from both countries, and grantees to spotlight local health innovations and community-led responses.

We shared early insights from our SAFEStart+ project, which focuses on improving maternal and newborn health through country-led and community-centered approaches. The project is accelerating demand and adoption of evidence-based approaches and integrated delivery strategies to eliminate vertical transmission of HIV, syphilis, HBV, and Chagas disease.

Thank you to Unitaid, STOPAIDS, WACI Health, and the SANAC Civil Society Forum for convening this important platform for dialogue and collaboration.

Read more about the SAFEStart+ project: https://bit.ly/4mqZ9pC

A new PATH-led research trial in   is assessing how an AI knowledge assistant can help community health workers better t...
08/05/2025

A new PATH-led research trial in is assessing how an AI knowledge assistant can help community health workers better triage and treat their patients.

The study will provide crucial insights on how LLMs such as ChatGPT and Gemini perform when asked health questions in an African context and in regional African languages, like Kinyarwanda.

This research is conducted in partnership with Rwanda Centre for the Fourth Industrial Revolution, Digital Umuganda, Rwanda Biomedical Centre, and University of Global Health Equity.

Learn more: https://bit.ly/40MpPJe

PATH and partners are conducting a research trial to assess how an AI knowledge assistant can help community health workers better triage and treat their patients.

📢 Join PATH, NEST360, World Health Organization (WHO), Preemie Love Foundation, and more partners *tomorrow* for an impo...
08/04/2025

📢 Join PATH, NEST360, World Health Organization (WHO), Preemie Love Foundation, and more partners *tomorrow* for an important webinar on how to promote lactation for small and sick newborns and their mothers.

📅 Tuesday, August 5
🕒 8am EDT / 3pm EAT / 5:30pm IST
📍 Join here: https://bit.ly/4lYZjop

This  , we're highlighting our collaboration with Nairobi County, The Ministry of Health Kenya, and the Children's Inves...
08/04/2025

This , we're highlighting our collaboration with Nairobi County, The Ministry of Health Kenya, and the Children's Investment Fund Foundation to improve health outcomes for mothers and babies.

The Mother-Baby Friendly Initiative Plus (MBFI+) is a comprehensive care model that addresses the unique challenges faced by small and sick newborns and their mothers. In Nairobi County, this holistic approach will be implemented in three health facilities: https://bit.ly/4iYg1md

🤱

MBFI+ is a comprehensive care model to optimize feeding and save lives of SSNBs. This systems strengthening approach links kangaroo mother care, nurturing care, psychosocial support, specialized lactation support, locally appropriate human milk banking,...

What if a medicine dose could come ready to use in one tiny, prefilled device? That’s exactly what PATH’s Uniject™ syste...
08/01/2025

What if a medicine dose could come ready to use in one tiny, prefilled device? That’s exactly what PATH’s Uniject™ system does—combining a needle, syringe, and medicine in a single package. It’s been used over 194 million times: from newborn hepatitis B vaccines to self-administered birth control.

💉 PATH: The way to better health.

Earlier this month, Da Lat hosted one of Vietnam’s most vibrant community events: the 2025 National Shuffle Dance, Sport...
07/30/2025

Earlier this month, Da Lat hosted one of Vietnam’s most vibrant community events: the 2025 National Shuffle Dance, Sport Dance, and Folk Dance Competition. 💃

Organized by the Sports Authority of Viet Nam, Lam D**g Department of Culture, Sports and Tourism, and PATH, the event marked a key achievement under the International Olympic Committee-funded Community Sport and Health Initiative.

The competition featured:
✔️ 1,000+ athletes from 21 provinces.
✔️ 5 dance categories, with participants aged 6–70.
✔️ A shared commitment to health, inclusion, and community connection.

We are proud to support this initiative to:
📢 Raise awareness of how physical activity helps prevent NCDs.
🏃 Embed movement into daily life, especially in schools.
💰 Mobilize investment for sport-for-health programs.
📈 Scale community-driven models to inform policies and inspire action.

Read more: https://bit.ly/4l0BLOI

Ủy ban Olympic Việt Nam

Highly effective HPV vaccines have been available since 2006, but they remain out of reach for many girls and women in l...
07/29/2025

Highly effective HPV vaccines have been available since 2006, but they remain out of reach for many girls and women in low- and middle-income countries, where about 94% of global cervical cancer deaths occur.

In 2020, PATH launched a project to increase global HPV vaccine availability, inform policy decisions, and help overcome LMICs’ most common barriers to access. Five years later, the project has come to a close, leaving behind a long list of successes.

From World Health Organization (WHO) endorsement of the bivalent HPV vaccine Cecolin for single-dose use to a robust portfolio of health economic analyses and decision-making tools for country leaders, the world has more resources to protect girls from cervical cancer than ever before.

Read more: https://bit.ly/4l1qP3t

PATH's HPV Vaccine Safety, Immunogenicity, and Health Economics (HPV SIHE) project is coming to a close after five years--and it leaves a long list of successes behind.

90% of infants infected with hepatitis B at birth develop a chronic, lifelong infection. This threat to newborns’ lives ...
07/28/2025

90% of infants infected with hepatitis B at birth develop a chronic, lifelong infection. This threat to newborns’ lives is largely preventable.

Administering the birth dose vaccine within 24 hours of birth can prevent 75–95% of these vertically transmitted infections. It's a critical intervention that can change a baby's life trajectory.

Despite its importance, timely access to this vaccine faces complex challenges. That's why PATH, Gavi, the Vaccine Alliance, and Unitaid have forged an innovative partnership that pools resources to research these barriers, identify effective strategies, and inform global efforts to scale up access.

This initiative will bring care into communities, reduce fragmentation, and design services that respond to the needs of women, newborns, and frontline providers. By working together, we can ensure more babies receive this lifesaving protection and a healthier start. 💪

Learn more: https://bit.ly/40GYTuq

PATH is committed to advancing   vaccine development and helping to protect infants worldwide from this deadly disease. ...
07/28/2025

PATH is committed to advancing vaccine development and helping to protect infants worldwide from this deadly disease.

We’ve published two new resources to aid researchers, developers, policymakers, regulators, and donors in following new and ongoing GBS development efforts:

➡️ The clinical trial tracker compiles a wide range of publicly available information on active GBS vaccine trials collected from multiple sources: https://bit.ly/3UnhsA6

➡️ The vaccine snapshot provides an at-a-glance looks at the GBS vaccine technology landscape: https://bit.ly/4kRqYpQ

These resources are designed to provide complementary information and will be updated twice a year.

Group B Strep International

  is a deadly disease for infants that can cause problems during pregnancy and result in miscarriage, premature delivery...
07/25/2025

is a deadly disease for infants that can cause problems during pregnancy and result in miscarriage, premature delivery, and stillbirth. There’s no vaccine to prevent it—yet.

This International Group B Strep Awareness Month, we’re celebrating the progress made so far. We’re working with Inventprise Inc., NYU Langone Health, and Wits VIDA to advance a new vaccine candidate that uses a strategy to protect babies from the moment they’re born.

🔗 https://bit.ly/3WJAClr

Group B Strep International

Some babies can’t breastfeed—but they still need the benefits of breast milk. PATH created the Nifty Feeding Cup so moms...
07/25/2025

Some babies can’t breastfeed—but they still need the benefits of breast milk. PATH created the Nifty Feeding Cup so moms can safely feed expressed milk to their babies, even in the toughest conditions. Now in 40+ countries, more than 80,000 cups are helping infants grow up strong and healthy.

PATH: The way to better health.

Address

437 N 34th Street
Seattle, WA
98103

Alerts

Be the first to know and let us send you an email when PATH posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share